FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die nicht zum Universitätsklinikum Erlangen gehören
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie
Overview
Publications
(288)
Research Grants
(4)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs (2023)
Weisbach L, Schuster AK, Hartmann M, Dürr P, Then M, Andrikyan W, Fromm M, et al.
Journal article, Original article
Transcriptional Regulation of Liver-Type OATP1B3 (Lt-OATP1B3) and Cancer-Type OATP1B3 (Ct-OATP1B3) Studied in Hepatocyte-Derived and Colon Cancer-Derived Cell Lines (2023)
Haberkorn B, Löwen D, Meier L, Fromm M, König J
Journal article
Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells (2023)
Zimmermann T, Stäbler S, Taudte RV, Ünüvar S, Groesch S, Arndt S, Karrer S, et al.
Journal article
Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021 (2023)
Then M, Tuemena T, Sledziewska A, Gassmann KG, Maas R, Fromm M
Journal article, Original article
L-Arginine metabolism inhibits arthritis and inflammatory bone loss (2023)
Cao S, Li Y, Song R, Meng X, Fuchs M, Liang C, Kachler K, et al.
Journal article
A supervised machine-learning approach for the efficient development of a multi method (LC-MS) for a large number of drugs and subsets thereof: Focus on oral antitumor agents (2023)
Kehl N, Geßner A, Maas R, Fromm M, Taudte V
Journal article
Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists (2023)
Graßl F, Bock L, Huete-Huerta González Á, Schiller M, Gmeiner P, König J, Fromm M, et al.
Journal article
N1-Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid (2023)
Müller F, Hohl K, Keller S, Schmidt-Gerets S, Deutsch B, Schuler-Metz A, Fromm M, et al.
Journal article
Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data (2023)
Andrikyan W, Jung-Poppe L, Altenbuchner A, Nicolaus HF, Pfistermeister B, Dormann H, Fromm M, Maas R
Journal article, Original article
Cancer-Type Organic Anion Transporting Polypeptide 1B3 Is Localized in Lysosomes and Mediates Resistance against Kinase Inhibitors (2022)
Haberkorn B, Oswald S, Kehl N, Geßner A, Taudte V, Dobert J, Zunke F, et al.
Journal article
‹
1
2
3
4
...
14
›